Biomedical Engineering Reference
In-Depth Information
ies that could lead to the discovery of novel disease biomarkers.
Obtaining both qualitative and quantitative information also pro-
vides deeper and more comprehensive insights into the origin and
structure of biological systems by allowing global proteomic pro-
filing. Regardless of the method of choice, quantitative analysis
requires an added degree of stringency, especially when analyz-
ing complex samples taken from patients suffering from complex
diseases such as neuropsychiatric diseases, which are polygenic,
multi-symptomatic, and present with overlapping symptoms.
In order for proteomic profiling experiments to be statistically
powered, it is necessary to investigate large sample cohorts.
As discussed in more detail in
Chapters 1
and
2
of this vol-
ume, there are several different platforms used for global pro-
teomic quantitative profiling. Among the most popular are gel-
based and isotopic-labeling methods, and protocols for these are
outlined in
Chapters 11
,
12
,
14
,
15
and
16
of this volume; how-
ever, these come with difficulties in meeting some of the require-
consistency of the platform performance so that biological dif-
ferences can be sufficiently distinguished from instrumental ones,
along with successful validation of quantitative significance; and
pooled samples. The necessity to analyze as many discrete (non-
pooled) samples as possible cannot be overestimated. Greater
n
-numbers enable researchers to apply a variety of statistical meth-
ods and increase the statistical power of the analysis that are not
possible when analyzing only a handful of samples or pooled sam-
ples. Furthermore, by analyzing samples in a discrete manner it
is possible to investigate subpopulations within a given group as
well as verify whether any demographics influence the underlying
proteomic profile.
There are several methodologies for label-free relative quan-
titation of proteins. The basic strategy is similar for all meth-
ods where the samples are analyzed sequentially and discretely
where neither proteins nor peptides are labeled. Thus the relative
quantitation relies on reproducible intensity measurements by the
MS. The label-free methods are distinguished by the MS mode
of operation, a defining factor for the analysis. There are four
types of strategies: the first two rely on acquiring data in data-
dependant analysis mode (DDA) and in the second two methods
A DDA experiment is typically a serial process. The cycle starts
by acquiring an MS survey scan followed by the selection of a
number of precursor ions for fragmentation (MS/MS) that may
Search WWH ::
Custom Search